These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24781241)

  • 21. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat.
    Sharma HS; Zimmermann-Meinzingen S; Johanson CE
    Ann N Y Acad Sci; 2010 Jun; 1199():125-37. PubMed ID: 20633118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.
    Allegri RF; Guekht A
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():25-41. PubMed ID: 22514793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role and Impact of Cerebrolysin for Ischemic Stroke Care.
    Mureșanu DF; Livinț Popa L; Chira D; Dăbală V; Hapca E; Vlad I; Văcăraș V; Popescu BO; Cherecheș R; Strilciuc Ș; Brainin M
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases.
    Alvarez XA; Alvarez I; Iglesias O; Crespo I; Figueroa J; Aleixandre M; Linares C; Granizo E; Garcia-Fantini M; Marey J; Masliah E; Winter S; Muresanu D; Moessler H
    Int J Neuropsychopharmacol; 2016 Jun; 19(6):. PubMed ID: 27207906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.
    Sharma HS; Menon PK; Lafuente JV; Aguilar ZP; Wang YA; Muresanu DF; Mössler H; Patnaik R; Sharma A
    J Nanosci Nanotechnol; 2014 Jan; 14(1):577-95. PubMed ID: 24730284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons.
    Hartbauer M; Hutter-Paier B; Skofitsch G; Windisch M
    J Neural Transm (Vienna); 2001; 108(4):459-73. PubMed ID: 11475013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Apoptosis in neuronal structures and the role of neurotrophic growth factors. Biochemical mechanisms of brain derived peptide preparations].
    Gomazkov OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; (Suppl 7):17-21. PubMed ID: 12747095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide profiling of Internet-obtained Cerebrolysin using high performance liquid chromatography - electrospray ionization ion trap and ultra high performance liquid chromatography - ion mobility - quadrupole time of flight mass spectrometry.
    Gevaert B; D'Hondt M; Bracke N; Yao H; Wynendaele E; Vissers JP; De Cecco M; Claereboudt J; De Spiegeleer B
    Drug Test Anal; 2015 Sep; 7(9):835-42. PubMed ID: 26017115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
    Kojder K; Jarosz K; Bosiacki M; Andrzejewska A; Zacha S; Solek-Pastuszka J; Jurczak A
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of Brain-Derived Neurotrophic Factor (BDNF) Expression in the Affected Neural Cells: A Preliminary Clue Obtained Through an In Vitro Study.
    P A; Rengarajan S; Venkatachalam S; Pattabi S; Jones S; K P; Krishna V; Prasanth K
    Cureus; 2024 Feb; 16(2):e54665. PubMed ID: 38524067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reinnervation of the rat musculocutaneous nerve stump after its direct reconnection with the C5 spinal cord segment by the nerve graft following avulsion of the ventral spinal roots: a comparison of intrathecal administration of brain-derived neurotrophic factor and Cerebrolysin.
    Haninec P; Dubový P; Sámal F; Houstava L; Stejskal L
    Exp Brain Res; 2004 Dec; 159(4):425-32. PubMed ID: 15351925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.
    Schauer E; Wronski R; Patockova J; Moessler H; Doppler E; Hutter-Paier B; Windisch M
    J Neural Transm (Vienna); 2006 Jul; 113(7):855-68. PubMed ID: 16362636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrolysin Concentrate: Therapeutic Potential for Severe Oral Apraxia After Stroke: A Case Report.
    Jeon H; Kim DY
    Brain Neurorehabil; 2024 Jul; 17(2):e11. PubMed ID: 39113920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Cerebrolysin in combination with high-dose aspirin antithrombotic treatment of ischemic stroke: A case report.
    Borisevich A; Veremeyuk K
    Clin Case Rep; 2021 Sep; 9(9):e04863. PubMed ID: 34594556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neurotoxicity: modulatory roles of co-morbidity factors and nanoparticle intoxication.
    Sharma HS; Sharma A; Mössler H; Muresanu DF
    Int Rev Neurobiol; 2012; 102():249-76. PubMed ID: 22748833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of cerebrolysin on disadaptation syndrome in patients with ischemic stroke].
    Iakupov EZ; Ovsiannikova KS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8 Pt 2):34-8. PubMed ID: 25345642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of cerebrolysin in cerebral hemorrhage model in rats].
    Kositsyn NS; Svinov MM; Goloborod'ko EV; Bozhevalova SV; Iablonskaia AM
    Eksp Klin Farmakol; 2006; 69(6):27-30. PubMed ID: 17209460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of the multicenter prospective study of cerebrolysin safety and efficacy in acute stroke].
    Skwortsova VI; Stakhovskaia LV; Shamalov NA; Kerbikov OB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():41-5. PubMed ID: 18196634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.